The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their crucial role in global healthcare. This move reinforces India’s position as a key provider of affordable generic medicines. Leaders highlight the strategic importance of the bilateral trade relationship, with the exemption offering India a chance to enhance its pharmaceutical sector.
Related Posts
‘What if bomb drops on your head?’: Trump’s dig at reporter
In a tense Oval Office meeting, President Trump rebuked Ukrainian President Zelenskyy, questioning Ukraine’s position in peace talks with Russia and criticizing Zelenskyy’s attitude toward […]
Recruiting profs in India: What UGC needs to change and why
India’s higher education institutions rely heavily on academic scores and publication records when hiring faculty. This approach often overlooks candidates with valuable industry experience and […]
Golden Globes: Payal Kapadia opts for handwoven outfit by this designer
Payal Kapadia is the first Indian director nominated for Best Director (Motion Picture) at the 82nd Golden Globe Awards. Her film, ‘All We Imagine As […]